Luisa Foltran

1.7k total citations
40 papers, 521 citations indexed

About

Luisa Foltran is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Luisa Foltran has authored 40 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Luisa Foltran's work include Colorectal Cancer Treatments and Studies (13 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Cancer Genomics and Diagnostics (8 papers). Luisa Foltran is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Cancer Genomics and Diagnostics (8 papers). Luisa Foltran collaborates with scholars based in Italy, Ukraine and United States. Luisa Foltran's co-authors include Michela Guardascione, Giuseppe Aprile, Gianpiero Fasola, Giuseppe Toffoli, Fabio Puglisi, Erika Cecchin, Elena De Mattia, Stefania Eufemia Lutrino, Mario D’Andrea and Francesco Angelini and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Luisa Foltran

37 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luisa Foltran Italy 14 256 127 121 110 68 40 521
Leung Li Hong Kong 14 209 0.8× 132 1.0× 104 0.9× 98 0.9× 109 1.6× 33 571
Anatole Cessot France 12 328 1.3× 137 1.1× 195 1.6× 81 0.7× 42 0.6× 30 562
Sachin Shah United States 13 286 1.1× 211 1.7× 172 1.4× 57 0.5× 54 0.8× 25 737
Xinjun Liang China 13 212 0.8× 114 0.9× 66 0.5× 86 0.8× 61 0.9× 46 528
Mustafa Altınbaş Türkiye 12 202 0.8× 145 1.1× 120 1.0× 69 0.6× 103 1.5× 47 670
Viola Barucca Italy 13 343 1.3× 90 0.7× 111 0.9× 116 1.1× 115 1.7× 19 496
Zhuqing Shi United States 15 180 0.7× 207 1.6× 358 3.0× 98 0.9× 67 1.0× 67 794
Anna Maria Elisabeth Walenkamp Netherlands 9 271 1.1× 117 0.9× 68 0.6× 73 0.7× 79 1.2× 17 467
So Yeon Kim United States 8 282 1.1× 258 2.0× 271 2.2× 134 1.2× 51 0.8× 21 771
Jennifer Wu United States 12 181 0.7× 206 1.6× 95 0.8× 127 1.2× 49 0.7× 39 579

Countries citing papers authored by Luisa Foltran

Since Specialization
Citations

This map shows the geographic impact of Luisa Foltran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Foltran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Foltran more than expected).

Fields of papers citing papers by Luisa Foltran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisa Foltran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Foltran. The network helps show where Luisa Foltran may publish in the future.

Co-authorship network of co-authors of Luisa Foltran

This figure shows the co-authorship network connecting the top 25 collaborators of Luisa Foltran. A scholar is included among the top collaborators of Luisa Foltran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisa Foltran. Luisa Foltran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nardo, Paola Di, et al.. (2025). Precision oncology in biliary tract cancer: the emerging role of liquid biopsy. ESMO Open. 10(5). 105079–105079. 1 indexed citations
2.
3.
Roncato, Rossana, Alessia Bignucolo, Elena Peruzzi, et al.. (2024). Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer. JAMA Network Open. 7(12). e2449441–e2449441. 7 indexed citations
4.
5.
Nardo, Paola Di, et al.. (2023). Liquid biopsy in colorectal cancer: Onward and upward. Critical Reviews in Oncology/Hematology. 194. 104242–104242. 15 indexed citations
6.
Nardo, Paola Di, Debora Basile, Ana Paula dos Reis Velloso Siciliano, et al.. (2023). Second-line treatment strategies for RAS wild-type colorectal cancer: A systematic review and Network Meta-analysis (NMA). Digestive and Liver Disease. 56(5). 786–794.
7.
Michelotti, A., Michela Guardascione, Rossana Roncato, et al.. (2021). NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome. Cells. 10(8). 2034–2034. 29 indexed citations
8.
Innocente, R., Federico Navarria, Roberto Petri, et al.. (2021). Feasibility and Oncological Outcome of Preoperative Chemoradiation With IMRT Dose Intensification for Locally Advanced Esophageal and Gastroesophageal Cancer. Frontiers in Oncology. 11. 626275–626275. 2 indexed citations
9.
Posocco, Bianca, Michela Guardascione, Luisa Foltran, et al.. (2021). A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring. PLoS ONE. 16(10). e0259137–e0259137. 10 indexed citations
10.
Fornasarig, Mara, Daniela Gasparotto, Luisa Foltran, et al.. (2020). A Novel Kindred with Familial Gastrointestinal Stromal Tumors Caused by a Rare KIT Germline Mutation (N655K): Clinico-Pathological Presentation and TKI Sensitivity. Journal of Personalized Medicine. 10(4). 234–234. 12 indexed citations
11.
Gagno, Sara, Elena Marangon, Michela Guardascione, et al.. (2020). A LC–MS/MS method for therapeutic drug monitoring of sorafenib, regorafenib and their active metabolites in patients with hepatocellular carcinoma. Journal of Pharmaceutical and Biomedical Analysis. 187. 113358–113358. 15 indexed citations
12.
Lisanti, C., Debora Basile, Elisa Bertoli, et al.. (2020). The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancer. Journal of Geriatric Oncology. 11(8). 1268–1273. 9 indexed citations
13.
Roncato, Rossana, Silvia Mezzalira, Elena De Mattia, et al.. (2019). FARMAPRICE: A Pharmacogenetic Clinical Decision Support System for Precise and Cost-Effective Therapy. Genes. 10(4). 276–276. 16 indexed citations
14.
Mattia, Elena De, Erika Cecchin, Michela Guardascione, et al.. (2019). Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma. World Journal of Gastroenterology. 25(29). 3870–3896. 67 indexed citations
15.
Abate, Riziero Esposito, Raffaella Pasquale, Alessandra Sacco, et al.. (2019). Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib. Cancers. 11(10). 1431–1431. 7 indexed citations
16.
Cappuzzo, Federico, Alessandro Morabito, Nicola Normanno, et al.. (2016). Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer. Lung Cancer. 99. 31–37. 30 indexed citations
17.
Foltran, Luisa, Giuseppe Aprile, Federica Pisa, et al.. (2014). Risk of unplanned visits for colorectal cancer outpatients receiving chemotherapy: a case-crossover study. Supportive Care in Cancer. 22(9). 2527–2533. 14 indexed citations
18.
19.
Berretta, Massimiliano, Giuseppe Aprile, Guglielmo Nasti, et al.. (2013). Oxaliplapin and Capecitabine (XELOX) Based Chemotherapy in the Treatment of Metastatic Colorectal Cancer: The Right Choice in Elderly Patients. Anti-Cancer Agents in Medicinal Chemistry. 13(9). 1344–1353. 12 indexed citations
20.
Aprile, Giuseppe, Claudio Avellini, Michele Reni, et al.. (2012). Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma. Tumor Biology. 34(1). 131–137. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leung Li Breakdown of academic impact, for papers by Anatole Cessot Breakdown of academic impact, for papers by Sachin Shah Breakdown of academic impact, for papers by Xinjun Liang Breakdown of academic impact, for papers by Mustafa Altınbaş Breakdown of academic impact, for papers by Viola Barucca Breakdown of academic impact, for papers by Zhuqing Shi Breakdown of academic impact, for papers by Anna Maria Elisabeth Walenkamp Breakdown of academic impact, for papers by So Yeon Kim Breakdown of academic impact, for papers by Jennifer Wu
Rankless by CCL
2026